Evaluation of myocardial viability in patients with myocardial ischemia reperfusion injury using the dual-energy CT myocardial blood pool imaging.

OBJECTIVES: To evaluate myocardial viability in patients with myocardial ischemia reperfusion injury (MIRI) via dual-energy computed tomography myocardial blood pool imaging (DECT MBPI). METHODS: Between September 2017 and January 2019, we prospectively recruited 59 patients with acute myocardial infarction (AMI) who developed MIRI after revascularization during invasive coronary angiography (ICA). Then, they received DECT MBPI, SPECT, and PET sequentially within 1 week after the onset of MIRI. A total of 1003 myocardial segments of 59 patients were recruited for this study. The iodine reduction areas and delayed enhancement areas were calculated by cardiac iodine map with SPECT rest myocardial perfusion imaging (MPI) + PET myocardial metabolism imaging (MMI) as reference criteria. The paired sample t-test was used to measure the difference of the myocardial iodine value. Cohen's Kappa analysis was used to test the consistency among different observers. ROC analysis was used to calculate the myocardial viability of DECT MBPI. RESULTS: ROC showed the AUCs of DECT MBPI iodine value to identify a normal myocardium, an ischemic myocardium, and an infarcted myocardium were 0.957, 0.900, and 0.906 (p < 0.001). The sensitivity, specificity, and accuracy of DECT MBPI in identifying an ischemic myocardium were 87.6%, 89.3%, and 97.9% (p < 0.001). The sensitivity, specificity, and accuracy of DECT MBPI in identifying an infarcted myocardium were 88.9%, 92.2%, and 98.6% (p < 0.001). The cutoff value for DECT MBPI to differentiate between an ischemic and a normal myocardium was 0.84 mg I/mL. The cutoff value for DECT MBPI to differentiate between an infarct and a normal myocardium was 2.01 mg I/mL. CONCLUSION: DECT MBPI can be used to assess myocardial viability in patients with MIRI with high sensitivity and specificity. KEY POINTS: • Dual-energy computed tomography myocardial blood pool imaging (DECT MBPI) can evaluate myocardial viability of myocardial ischemia-reperfusion injury (MIRI). • DECT MBPI is a non-invasive and timesaving method for evaluation on myocardial ischemia-reperfusion injury in patients with acute myocardial infarction after coronary intervention.

The value of mobile magnetic resonance imaging in early warning for stroke: A prospective case-control study.

Aims: To evaluate the predictive value of mobile magnetic resonance imaging (MRI) in screening stroke. Methods: This was a prospective case-control study performed on healthy residents over 40 years old in remote rural areas of northern China between May 2019 and May 2020. Multivariate logistic regression and receiver operator characteristic curve (ROC) analysis were used to evaluate the screening model. Results: A total of 1,224 patients (500 [40.8%] men) enrolled, including 56 patients who suffered from stroke (aged 64.05 ± 7.27). The individuals who developed stroke were significantly older (P < 0.001), had a significantly higher occurrence of heart disease (P = 0.015), diabetes (P = 0.005), dyslipidemia (P = 0.009), and significantly increased waist circumference (P = 0.02), systolic blood pressure (SBP) (P = 0.003), glycosylated hemoglobin (HbA1c) level (P = 0.007), triglyceride (TG) level (P = 0.025), low density lipoprotein cholesterol (LDL-c) level (P = 0.04), and homocysteine (HCY) level (P < 0.001). Multivariate logistic regression analysis showed that age (OR = 1.055, 95% CI: 1.017-1.094, P = 0.004), HCY (OR = 1.029, 95% CI: 1.012-1.047, P = 0.001) and mobile MRI (OR = 4.539, 95% CI: 1.726-11.939, P = 0.002) were independently associated with stroke. The area under the curve (AUC) of the combined model including national screening criteria, mobile MRI results, and stroke risk factors was 0.786 (95% CI: 0.721-0.851), with a sensitivity of 69.6% and specificity of 80.4%. Conclusion: Mobile MRI can be used as a simple and easy means to screen stroke.

Impact of CircRNAs on Ischemic Stroke.

Circular RNA (circRNA) is a recently discovered class of endogenous non-coding RNA that is generated by cyclization, driven by intron pairing, and regulated by related regulators. An important biological function of CircRNA is acting as a molecular sponge to significantly alter miRNA levels over a short period. Several studies have shown that circRNA is closely related to stroke. Therefore, a better understanding of CircRNA function and regulatory mechanism in ischemic brain will help us for the early detection, early diagnosis, and early treatment of stroke. Here, we summary the biological characteristics, expression of circRNA, and its effect on outcome after ischemic stroke.

Evaluation of high-pitch dual-source CT angiography for evaluation of coronary and carotid-cerebrovascular arteries.

OBJECTIVES: To explore the feasibility and diagnostic accuracy of a combined one-step high-pitch dual-source computed tomography angiography (CTA) technique for evaluation of coronary and carotid-cerebrovascular arteries. MATERIALS AND METHODS: 85 symptomatic patients suspected of coronary artery and cerebrovascular disease referred for simultaneous coronary and carotid-cerebrovascular CTA were included. Additional invasive angiography of the coronary and cerebral arteries was performed within 30 days in 23 and 13 patients, respectively. The objective parameters of image quality, the mean CT attenuations, image noise, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) were evaluated. The subjective image quality of vessels was also assessed by 2 independent radiologists blinded to the patients' medical history and scan protocols. The diagnostic performance of CTA including sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the detection or exclusion of significant artery stenosis was calculated using the chi-squared test of contingency and correlated with the results of invasive angiography representing the standard of reference. RESULTS: Image quality was rated excellent (score 1) in 95.3% (1074/1127), good (score 2) in 3.3% (37/1127), adequate (score 3) in 1.0% (11/1127), and non-diagnostic (score 4) in 0.4% (5/1127) of coronary segments. Image quality of carotid and cerebral vessels was rated mostly excellent (score 1, 95.12% [78/82]; score 2, 3.66% [3/82]; score 3, 1.22% [1/82]). The sensitivity, specificity, PPV and NPV for the detection of coronary stenosis were 92.2% (81.1-97.7%), 95.2% (91.7-97.5%), 79.6% (67.1-89.1%) and 98.3% (95.8-99.5%), respectively. For the detection of carotid and cerebral artery stenosis, CTA demonstrated a sensitivity of 92.8% (80.5-98.4%), a specificity of 93.5% (88.3-96.8%), a PPV of 79.6% (65.6-89.7%) and a NPV of 97.9% (94.1-99.5%). The effective radiation dose was 1.42±0.44mSv (range, 0.88-3.35mSv). CONCLUSION: Dual-source CT with a one-step high-pitch scan protocol for combined coronary and carotid-cerebrovascular CTA provides good image quality and a high diagnostic accuracy for the simultaneous evaluation of coronary, carotid and cerebral artery stenosis and may be a useful examination with relatively low radiation exposure in patients with suspected coronary and carotid-cerebrovascular disease.